BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 19, 2015
View Archived Issues
Merck & Co. describes discovery of novel DGAT2 inhibitors
Read More
Discovery and optimization of novel HIV integrase inhibitors from BMS
Read More
DelMar Pharmaceuticals receives additional funding to develop VAL-083
Read More
Novartis gives details on early testing of potent BCR-ABL allosteric inhibitor
Read More
Omeros reports additional data from phase II trial of OMS-721
Read More
Novel SYK inhibitor shows antitumor activity in preclinical models
Read More
FDA accepts filing of supplemental BLA for Keytruda
Read More
New translocator protein ligands target mitochondrial dysfunction in Alzheimer's disease
Read More
Bristol-Myers Squibb patents factor XIa and KLKB1 inhibitors
Read More
TUBE Pharmaceuticals discloses cytotoxic compounds for cancer
Read More
Roche develops PDE10A inhibitors
Read More
FDA approves first treatment for hypoactive sexual desire disorder in women
Read More
Enanta Pharmaceuticals designs anti-HCV agents
Read More
Remedy Pharmaceuticals starts pilot trial of Cirara for spinal cord injury
Read More
Theravance Biopharma patent discloses NEP inhibitors
Read More
Biohaven acquires ALS Biopharma glutamate signaling modulator portfolio
Read More
FDA awards QIDP status to Matinas BioPharma's encochleated amphotericin B
Read More
Kadimastem's astrocyte therapy increases survival in animal model of ALS
Read More
Lilly launches Humalog U-200 KwikPen in U.S.
Read More
Intarcia reports results from ITCA-650 phase III trial FREEDOM-2
Read More
NantKwest starts phase II trial of NK-92 in Merkel cell carcinoma
Read More
Peptide drug developer Phoundry Pharmaceuticals completes financing
Read More
Phase II study examines combination of pembrolizumab and IL-12 gene therapy in melanoma
Read More
Biogen announces ALS genomics collaboration
Read More
Bavarian Nordic initiates first-in-human study of RSV vaccine
Read More